Pill 208

Gradually reduce the dosage rather than stopping Citalopram abruptly whenever possible. Use MD’s Pill Identifier to find and identify any over-the-counter or prescription drug, pill, or medication by color, shape, or imprint and easily compare pictures of multiple drugs. Monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors, especially during the initial few months of drug therapy and at times of dosage changes.

Citalopram is indicated for the treatment of major depressive disorder MDD in adults [see Clinical Studies 14 ]. Pill Identifier results for " White and Round". Administer Citalopram once daily, with or without food, at an initial dosage of 20 mg once daily, with an increase to a maximum dosage of 40 mg once daily at an interval of no less than one week.

Warnings and Precautions 5. It is supplied by Cipla USA, Inc. Use MD’s Pill Identifier to find and identify any over-the-counter or prescription drug, pill, or medication by color, shape, or imprint and easily compare pictures of multiple drugs.

  • Pill with imprint I G is White, Round and has been identified as Citalopram Hydrobromide 40 mg. It is supplied by Cipla USA, Inc.

    • In pooled analyses of placebo-controlled trials of antidepressant drugs SSRIs and other antidepressant classes that included approximately 77, adult patients, and 4, pediatric patients, the incidence of suicidal thoughts and behaviors in antidepressant-treated patients age 24 years and younger was greater than in placebo-treated patients.

    However, there is substantial evidence from placebo-controlled maintenance trials in adults with MDD that antidepressants delay the recurrence of depression and that depression itself is a risk factor for suicidal thoughts and behaviors. Adverse reactions may occur upon discontinuation of Citalopram [see Warnings and Precautions 5.

    This pill is a white round tablet with imprint I G on it. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions 5. At least 14 days must elapse between discontinuation of a monoamine oxidase inhibitor MAOI antidepressant and initiation of therapy with Citalopram.

    Conversely, at least 14 days must elapse after stopping Citalopram before starting an MAOI antidepressant [see Contraindications 4 and Warnings and Precautions 5. It contains citalopram, a prescription drug used to treat various mental disorders and conditions. Counsel family members or caregivers of patients to monitor for changes in behavior and to alert the healthcare provider.

    Dosages above 40 mg once daily are not recommended due to the risk of QT prolongation [see Warnings and Precautions 5. The maximum recommended dosage of Citalopram for patients who are greater than 60 years of age, pills 208 with hepatic impairment, and for CYP2C19 poor metabolizers is 20 mg once daily [see Warnings and Precautions 5. There was considerable variation in risk of suicidal thoughts and behaviors among drugs, but there was an increased risk identified in young patients for most drugs studied.

    Citalopram is indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14)]. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions ()]. The maxium recommended dosage of Citalopram when used concomitantly with a CYP2C19 inhibitor is 20 mg once daily [see Warnings and Precautions 5.

    Recommended Dosage - Administer Citalopram once daily, with or without food, at an initial dosage of 20 mg once daily, with an increase to a maximum dosage of 40 mg once daily at an. If you are a consumer or patient please visit this version. There were differences in absolute risk of suicidal thoughts and behaviors across the different indications, with the highest incidence in patients with MDD. The drug-placebo differences in the number of cases of suicidal thoughts and behaviors per patients treated are provided in Table 1.

    It contains citalopram, a prescription drug used to treat various mental disorders and conditions. Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short- term studies. Citalopram is not approved for use in pediatric patients. Tablets: 10 mg; 20 mg, scored; and 40 mg, scored 3.

    WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short- term studies. Pill with imprint I G is White, Round and has been identified as Citalopram Hydrobromide 40 mg. Citalopram is not approved for use in pediatric patients [see Use in Specific Populations 8.

    Prior to initiating pill 208 with Citalopram or another antidepressant, screen patients for a personal or family history of bipolar disorder, mania, or hypomania [See Warnings and Precautions 5. Search by imprint, shape, color or drug name. Consider changing the therapeutic regimen, including possibly discontinuing Citalopram, in patients whose depression is persistently worse, or who are experiencing emergent suicidal thoughts or behaviors.

    Citalopram Hydrobromide by Exelan Pharmaceuticals Inc. is a white rou tablet about 10 mm in size, imprinted with ig; The product is a human prescription drug with active ingredient (s) citalopram. This pill is a white round tablet with imprint I G on it. It is unknown whether the risk of suicidal thoughts and behaviors in children, adolescents, and young adults extends to longer-term use, i.

    Pill Identifier results for " White and Round". Search by imprint, shape, color or drug name.